Emergent Biosolutions EBS Other — Total revenues
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Emergent Biosolutions in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: Emergent Biosolutions’s 10-K, filed February 27, 2026, on SEC EDGAR. View the filing →
Ask your AI about Emergent Biosolutions's other — total revenues.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Emergent Biosolutions's other — total revenues?
- Emergent Biosolutions (EBS) reported other — total revenues of $34.2M in Q4 2025.
- How has Emergent Biosolutions's other — total revenues changed year-over-year?
- Emergent Biosolutions's other — total revenues increased by 69.7% year-over-year, from $20.15M to $34.2M.
- What is the long-term trend for Emergent Biosolutions's other — total revenues?
- Over 4 years (2021 to 2025), Emergent Biosolutions's other — total revenues has grown at a 13.1% compound annual growth rate (CAGR), from $83.5M to $136.8M.
- What does other — total revenues mean?
- Represents the total gross revenue generated by business activities categorized within the 'Other' segment, which encompasses operations not captured by primary product or service lines. This metric is essential for assessing the contribution of ancillary or non-core business units to the company's overall top-line performance. Monitoring this figure helps investors understand the diversification of revenue streams outside of the firm's primary commercial offerings.